Cerus logo

Cerus

CERS | NASDAQ
Chart Builder DCF Calculator
$1.86
-$0.13 (-6.30%)
At close: Nov 16, 2026, 4:00 PM ET
$1.86
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET
-6.30%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
52
Fundamentals Average
Market Sentiment Neutral
Moat Narrow
Sector Rank #239/1021 (Top 23%)

Key Statistics

Market Data

Market Cap $375.63M
1D Range
1.84 1.97
52W Range
1.49 3.28

Valuation (TTM)

PE -47.94
PB 4.96
EV/EBITDA 494.68

Valuation (NTM)

Forward PE 256.00
Forward PEG 0.78
Price Target $4.00
Loading financial charts...

Profile

Cerus Corporation operates as a biotechnology firm dedicated to advancing and marketing the INTERCEPT Blood System. This proprietary technology significantly enhances the safety of transfusable blood ...

Sector Healthcare
Employees 268
IPO Date Jan 31, 1997
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 2, 2026
EPS
-$0
Beat +78.40%
REV
$64M
Beat +1.19%
Next Earnings
Mar 1, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
1
Consensus
Buy
Price Target
$4.00
Upside
+115.05%
Buy (1)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.